HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Philippe Spano Selected Research

Vaccines

11/2023Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.
3/2023One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort.
1/2022The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Philippe Spano Research Topics

Disease

68Neoplasms (Cancer)
04/2024 - 08/2002
19Breast Neoplasms (Breast Cancer)
10/2023 - 08/2002
8Melanoma (Melanoma, Malignant)
10/2022 - 08/2006
8Carcinogenesis
10/2014 - 05/2004
7Renal Cell Carcinoma (Grawitz Tumor)
11/2023 - 10/2011
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 09/2004
7Neoplasm Metastasis (Metastasis)
01/2019 - 04/2007
7Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 05/2005
6Carcinoma (Carcinomatosis)
08/2022 - 05/2004
5Infections
11/2023 - 05/2005
5Lung Neoplasms (Lung Cancer)
01/2021 - 01/2005
5Acquired Immunodeficiency Syndrome (AIDS)
11/2014 - 02/2002
4COVID-19
03/2023 - 01/2020
4Opportunistic Infections (Opportunistic Infection)
02/2022 - 01/2004
4Brain Neoplasms (Brain Tumor)
01/2019 - 05/2012
4Prostatic Neoplasms (Prostate Cancer)
01/2019 - 10/2009
3Hemorrhage
07/2023 - 04/2020
3Disease Progression
01/2022 - 04/2010
3Kaposi Sarcoma (Kaposi's Sarcoma)
01/2020 - 02/2002
2Chronic Disease (Chronic Diseases)
03/2023 - 01/2020
2Thrombosis (Thrombus)
02/2023 - 04/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2022 - 12/2021
2Immune Reconstitution Inflammatory Syndrome
02/2022 - 11/2021
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 11/2005
2Renal Insufficiency (Renal Failure)
12/2021 - 03/2012
2Rectal Neoplasms (Rectal Cancer)
01/2020 - 02/2003
2Anus Neoplasms (Anal Cancer)
11/2014 - 10/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2012 - 06/2008
2Anemia
01/2008 - 05/2005
1Liver Failure
12/2023
1Chronic Hepatitis B
12/2023
1Fetal Growth Retardation (Intrauterine Growth Retardation)
10/2023
1Neuroendocrine Carcinoma
06/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2023
1Squamous Cell Carcinoma of Head and Neck
10/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022

Drug/Important Bio-Agent (IBA)

11Immune Checkpoint InhibitorsIBA
04/2024 - 12/2018
9Biomarkers (Surrogate Marker)IBA
08/2016 - 01/2005
6Trastuzumab (Herceptin)FDA Link
10/2023 - 12/2010
6ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2006
5Hormones (Hormone)IBA
01/2019 - 12/2004
5Long Noncoding RNAIBA
01/2017 - 10/2014
5EnzymesIBA
10/2009 - 07/2006
4Lapatinib (GW572016)FDA Link
10/2023 - 12/2010
4Tyrosine Kinase InhibitorsIBA
02/2023 - 01/2005
4NivolumabIBA
01/2022 - 04/2017
4Cisplatin (Platino)FDA LinkGeneric
12/2021 - 01/2005
4Aromatase InhibitorsIBA
01/2019 - 01/2004
4Bevacizumab (Avastin)FDA Link
10/2018 - 01/2011
4ChromatinIBA
01/2017 - 09/2004
4AnthracyclinesIBA
11/2014 - 08/2002
4GemcitabineFDA Link
09/2012 - 08/2002
3Antineoplastic Agents (Antineoplastics)IBA
04/2024 - 10/2009
3VaccinesIBA
11/2023 - 01/2022
3AnticoagulantsIBA
07/2023 - 04/2020
3Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2004
3Monoclonal AntibodiesIBA
01/2021 - 01/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 08/2005
3Docetaxel (Taxotere)FDA Link
01/2011 - 01/2005
3CreatinineIBA
12/2010 - 01/2009
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2006 - 05/2004
2AntibodiesIBA
12/2023 - 03/2021
2Irinotecan (Camptosar)FDA LinkGeneric
06/2023 - 04/2007
2pembrolizumabIBA
08/2022 - 01/2019
2Antiviral Agents (Antivirals)IBA
01/2022 - 01/2020
2Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 01/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2019
2RNA (Ribonucleic Acid)IBA
08/2016 - 01/2015
2human ERBB2 proteinIBA
06/2015 - 06/2012
2Estrogen ReceptorsIBA
10/2014 - 01/2004
2Axitinib (AG 013736)IBA
08/2012 - 06/2008
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2012 - 06/2008
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
10/2009 - 01/2006
2ImmunosorbentsIBA
05/2009 - 08/2006
2TamoxifenFDA LinkGeneric
02/2009 - 12/2004
2Celecoxib (Celebrex)FDA Link
05/2004 - 05/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2004 - 05/2004
2rofecoxib (Vioxx)FDA Link
05/2004 - 05/2004
1Staphylococcal Protein A (Protein A)IBA
11/2023
1Ado-Trastuzumab EmtansineIBA
10/2023
1Fluorouracil (Carac)FDA LinkGeneric
06/2023
1PlatinumIBA
06/2023
1Messenger RNA (mRNA)IBA
03/2023
1COVID-19 VaccinesIBA
03/2023
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
02/2023
1Death Domain ReceptorsIBA
10/2022
1utomilumabIBA
10/2022

Therapy/Procedure

36Therapeutics
11/2023 - 01/2004
23Drug Therapy (Chemotherapy)
12/2023 - 02/2003
6Immunotherapy
11/2023 - 04/2010
5Radiotherapy
05/2014 - 02/2003
4Highly Active Antiretroviral Therapy (HAART)
11/2015 - 01/2006
3Adjuvant Chemotherapy
01/2020 - 02/2009
2Neoadjuvant Therapy
01/2020 - 01/2019
2Precision Medicine
12/2018 - 06/2013
2Castration
09/2017 - 07/2016
2Drug Tapering
12/2010 - 10/2009
1Molecular Targeted Therapy
02/2024
1Aftercare (After-Treatment)
12/2023